Toxicity of iron oxide nanoparticles against osteoblasts
Source abstract
Abstract
Magnetic nanoparticles have been widely used for tissue repair, magnetic resonance imaging, immunoassays and drug delivery. They are very promising in orthopaedic applications and several magnetic nanoparticles have been exploited for the treatment of orthopaedic disease. Here, we conducted an in vitro study to examine the interaction of magnetic iron oxide nanoparticles with human osteoblasts to evaluate the dose-related toxicity of the nanoparticles on osteoblasts. A transmission electron microscope was used to visualise the internalised magnetic nanoparticles in osteoblasts. The CCK-8 results revealed increased cell viability (107.5 % vitality compared with the control group) when co-cultured at a low concentration (20 μg/mL) and decreased cell viability (59.5 % vitality in a concentration of 300 μg/mL and 25.9 % in 500 μg/mL) when co-cultured in high concentrations. The flow cytometric detection revealed similar results with 5.48 % of apoptosis in a concentration of 20 μg/mL, 23.40 % of apoptosis in a concentration of 300 μg/mL and 28.49 % in a concentration of 500 μg/mL. The disrupted cytoskeleton of osteoblasts was also revealed using a laser scanning confocal microscope. We concluded that use of a low concentration of magnetic iron oxide nanoparticles is important to avoid damage to osteoblasts.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoparticles: synthesis and applications · Bone Tissue Engineering Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (37)
Show source-provided references
1. Apopa PL, Qian Y, Shao R, Guo NL, Schwegler-Berry D, Pacurari M, Porter D, Shi X, Vallyathan V, Castranova V, Flynn DC (2009) Iron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodeling. Part Fibre Toxicol 6:1. doi: 10.1186/1743-8977-6-110.1186/1743-8977-6-1 ↗
2. Arbab AS, Wilson LB, Ashari P, Jordan EK, Lewis BK, Frank JA (2005) A model of lysosomal metabolism of dextran coated superparamagnetic iron oxide (spio) nanoparticles: implications for cellular magnetic resonance imaging. NMR Biomed 18(6):383–389. doi: 10.1002/nbm.97010.1002/nbm.970 ↗
3. Berry CC, Wells S, Charles S, Curtis AS (2003) Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts in vitro. Biomaterials 24(25):4551–455710.1016/S0142-9612(03)00237-0 ↗
4. Berry CC, Wells S, Charles S, Aitchison G, Curtis AS (2004) Cell response to dextran-derivatised iron oxide nanoparticles post internalisation. Biomaterials 25(23):5405–5413. doi: 10.1016/j.biomaterials.2003.12.04610.1016/j.biomaterials.2003.12.046 ↗
5. Buyukhatipoglu K, Clyne AM (2011) Superparamagnetic iron oxide nanoparticles change endothelial cell morphology and mechanics via reactive oxygen species formation. J Biomed Mater Res A 96(1):186–195. doi: 10.1002/jbm.a.3297210.1002/jbm.a.32972 ↗
6. Frohlich E, Kueznik T, Samberger C, Roblegg E, Wrighton C, Pieber TR (2010) Size-dependent effects of nanoparticles on the activity of cytochrome p450 isoenzymes. Toxicol Appl Pharmacol 242(3):326–332. doi: 10.1016/j.taap.2009.11.00210.1016/j.taap.2009.11.002 ↗
7. Gupta AK, Gupta M (2005) Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26(18):3995–4021. doi: 10.1016/j.biomaterials.2004.10.01210.1016/j.biomaterials.2004.10.012 ↗
8. Gupta AK, Naregalkar RR, Vaidya VD, Gupta M (2007) Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications. Nanomedicine 2(1):23–3910.2217/17435889.2.1.23 ↗
9. Hong SC, Lee JH, Lee J, Kim HY, Park JY, Cho J, Han DW (2011) Subtle cytotoxicity and genotoxicity differences in superparamagnetic iron oxide nanoparticles coated with various functional groups. Int J Nanomed 6:3219–3231. doi: 10.2147/IJN.S26355ijn-6-3219
10. Kami D, Takeda S, Itakura Y, Gojo S, Watanabe M, Toyoda M (2011) Application of magnetic nanoparticles to gene delivery. Int J Mol Sci 12(6):3705–3722. doi: 10.3390/ijms1206370510.3390/ijms12063705 ↗
11. Lacava LM, Lacava ZG, Da Silva MF, Silva O, Chaves SB, Azevedo RB, Pelegrini F, Gansau C, Buske N, Sabolovic D, Morais PC (2001) Magnetic resonance of a dextran-coated magnetic fluid intravenously administered in mice. Biophys J 80(5):2483–2486. doi: 10.1016/S0006-3495(01)76217-010.1016/S0006-3495(01)76217-0 ↗
12. Laurent S, Mahmoudi M (2011) Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of cancer. Int J Mol Epidemiol Genet 2(4):367–390
13. Lee Y, Lee J, Bae CJ, Park JG, Noh HJ, Park JH, Hyeon T (2005) Large-scale synthesis of uniform and crystalline magnetite nanoparticles using reverse micelles as nanoreactors under reflux conditions. Adv Funct Mater 15(3):503–50910.1002/adfm.200400187 ↗
14. Lewin M, Carlesso N, Tung CH, Tang XW, Cory D, Scadden DT, Weissleder R (2000) Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol 18(4):410–414. doi: 10.1038/7446410.1038/74464 ↗
15. Mahmoudi M, Sant S, Wang B, Laurent S, Sen T (2011) Superparamagnetic iron oxide nanoparticles (spions): development, surface modification and applications in chemotherapy. Adv Drug Deliv Rev 63(1–2):24–46. doi: 10.1016/j.addr.2010.05.00610.1016/j.addr.2010.05.006 ↗
16. Masoudi A, Madaah Hosseini HR, Shokrgozar MA, Ahmadi R, Oghabian MA (2012) The effect of poly(ethylene glycol) coating on colloidal stability of superparamagnetic iron oxide nanoparticles as potential MRI contrast agent. Int J Pharm. doi: 10.1016/j.ijpharm.2012.04.080
17. Massart R (1981) Preparation of aqueous magnetic liquids in alkaline and acidic media. IEEE Trans Magn 17(2):1247–124810.1109/TMAG.1981.1061188 ↗
18. Murray AR, Kisin E, Inman A, Young SH, Muhammed M, Burks T, Uheida A, Tkach A, Waltz M, Castranova V, Fadeel B, Kagan VE, Riviere JE, Monteiro-Riviere N, Shvedova AA (2012) Oxidative stress and dermal toxicity of iron oxide nanoparticles in vitro. Cell Biochem Biophys. doi: 10.1007/s12013-012-9367-9
19. Naqvi S, Samim M, Abdin M, Ahmed FJ, Maitra A, Prashant C, Dinda AK (2010) Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress. Int J Nanomed 5:983–989. doi: 10.2147/IJN.S1324410.2147/IJN.S13244 ↗
20. Osaka T, Nakanishi T, Shanmugam S, Takahama S, Zhang H (2009) Effect of surface charge of magnetite nanoparticles on their internalization into breast cancer and umbilical vein endothelial cells. Colloids Surf B Biointerfaces 71(2):325–33010.1016/j.colsurfb.2009.03.004 ↗
21. Pareta RA, Taylor E, Webster TJ (2008) Increased osteoblast density in the presence of novel calcium phosphate coated magnetic nanoparticles. Nanotechnology 19(26):265101. doi: 10.1088/0957-4484/19/26/26510110.1088/0957-4484/19/26/265101 ↗
22. Rahimi M, Wadajkar A, Subramanian K, Yousef M, Cui W, Hsieh JT, Nguyen KT (2010) In vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled drug delivery. Nanomedicine 6(5):672–680. doi: 10.1016/j.nano.2010.01.01210.1016/j.nano.2010.01.012 ↗
23. Safi M, Courtois J, Seigneuret M, Conjeaud H, Berret JF (2011) The effects of aggregation and protein corona on the cellular internalization of iron oxide nanoparticles. Biomaterials 32(35):9353–9363. doi: 10.1016/j.biomaterials.2011.08.04810.1016/j.biomaterials.2011.08.048 ↗
24. Schlachter EK, Widmer HR, Bregy A, Lonnfors-Weitzel T, Vajtai I, Corazza N, Bernau VJ, Weitzel T, Mordasini P, Slotboom J, Herrmann G, Bogni S, Hofmann H, Frenz M, Reinert M (2011) Metabolic pathway and distribution of superparamagnetic iron oxide nanoparticles: in vivo study. Int J Nanomed 6:1793–1800. doi: 10.2147/IJN.S23638ijn-6-1793
25. Schlorf T, Meincke M, Kossel E, Gluer CC, Jansen O, Mentlein R (2010) Biological properties of iron oxide nanoparticles for cellular and molecular magnetic resonance imaging. Int J Mol Sci 12(1):12–23. doi: 10.3390/ijms1201001210.3390/ijms12010012 ↗
26. Selvan ST (2010) Silica-coated quantum dots and magnetic nanoparticles for bioimaging applications (mini-review). Biointerphases 5(3):FA110–FA115. doi: 10.1116/1.351649210.1116/1.3516492 ↗
27. Shi Z, Huang X, Cai Y, Tang R, Yang D (2009) Size effect of hydroxyapatite nanoparticles on proliferation and apoptosis of osteoblast-like cells. Acta Biomater 5(1):338–34510.1016/j.actbio.2008.07.023 ↗
28. Song M, Moon WK, Kim Y, Lim D, Song IC, Yoon BW (2007) Labeling efficacy of superparamagnetic iron oxide nanoparticles to human neural stem cells: comparison of ferumoxides, monocrystalline iron oxide, cross-linked iron oxide (clio)-nh2 and tat-clio. Korean J Radiol 8(5):365–37110.3348/kjr.2007.8.5.365 ↗
29. Sun S, Zeng H (2002) Size-controlled synthesis of magnetite nanoparticles. J Am Chem Soc 124(28):8204–820510.1021/ja026501x ↗
30. Tassa C, Shaw SY, Weissleder R (2011) Dextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapy. Acc Chem Res 44(10):842–852. doi: 10.1021/ar200084x10.1021/ar200084x ↗
31. Thorek DL, Tsourkas A (2008) Size, charge and concentration dependent uptake of iron oxide particles by non-phagocytic cells. Biomaterials 29(26):3583–3590. doi: 10.1016/j.biomaterials.2008.05.01510.1016/j.biomaterials.2008.05.015 ↗
32. Tong S, Hou S, Zheng Z, Zhou J, Bao G (2010) Coating optimization of superparamagnetic iron oxide nanoparticles for high T2 relaxivity. Nano Lett 10(11):4607–4613. doi: 10.1021/nl102623x10.1021/nl102623x ↗
33. Tran N, Webster TJ (2011) Increased osteoblast functions in the presence of hydroxyapatite-coated iron oxide nanoparticles. Acta Biomater 7(3):1298–1306. doi: 10.1016/j.actbio.2010.10.00410.1016/j.actbio.2010.10.004 ↗
34. Wang L, Wang ZH, Shen CY, You ML, Xiao JF, Chen GQ (2010) Differentiation of human bone marrow mesenchymal stem cells grown in terpolyesters of 3-hydroxyalkanoates scaffolds into nerve cells. Biomaterials 31(7):1691–169810.1016/j.biomaterials.2009.11.053 ↗
35. Wilhelm CBC, Roger J, Pons JN, Bacri C, Gazeau F (2002) Intracellular uptake of anionic superparamagnetic nanoparticles as a function o their surface coating. Biomaterials 24(6):1001–101110.1016/S0142-9612(02)00440-4 ↗
36. Wiogo HT, Lim M, Bulmus V, Yun J, Amal R (2011) Stabilization of magnetic iron oxide nanoparticles in biological media by fetal bovine serum (FBS). Langmuir 27(2):843–850. doi: 10.1021/la104278m10.1021/la104278m ↗
37. Zhang DE, Tong ZW, Li SZ, Zhang XB, Ying A (2008) Fabrication and characterization of hollow Fe3O4 nanospheres in a microemulsion. Mater Lett 62(24):4053–405510.1016/j.matlet.2008.05.023 ↗